Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Emory University announces new health institute

Emory University announces new health institute

BIO urges Congress to pass Stem Cell Research Enhancement Act

BIO urges Congress to pass Stem Cell Research Enhancement Act

Amphora sells oncology target to Genentech

Amphora sells oncology target to Genentech

Cytogen issued new patent covering oral drug delivery agents

Cytogen issued new patent covering oral drug delivery agents

Master stem cell capable of producing new heart tissue

Master stem cell capable of producing new heart tissue

New protein structure found - important for drug discovery

New protein structure found - important for drug discovery

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Lab-on-a-chip nanoscale array monitors cellular processes

Lab-on-a-chip nanoscale array monitors cellular processes

New study emphasizes the importance of metabolomics to the advent of personalized medicine

New study emphasizes the importance of metabolomics to the advent of personalized medicine

New method of developing antibiotics

New method of developing antibiotics

New map for human genome expression

New map for human genome expression

New drug improves blood flow in diseased arteries

New drug improves blood flow in diseased arteries

Ranbaxy wins two additional Atorvastatin patents in Norway

Ranbaxy wins two additional Atorvastatin patents in Norway

SRU Biosystems OK'd to conduct business

SRU Biosystems OK'd to conduct business

US patent granted for 4SC's clinical Project

US patent granted for 4SC's clinical Project

Evotec sells single molecule detection technology to Olympus

Evotec sells single molecule detection technology to Olympus

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates

Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates

SRU Biosystems awarded new U.S. patent

SRU Biosystems awarded new U.S. patent

Research could lead to new treatments for idiopathic pulmonary fibrosis

Research could lead to new treatments for idiopathic pulmonary fibrosis